Myriad Genetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. 

CEO
Samraat S Raha
CEOSamraat S Raha
Employees
2,700
Employees2,700
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1991
Founded1991
Employees
2,700
Employees2,700

MYGN Key Statistics

Market cap
437.30M
Market cap437.30M
Price-Earnings ratio
-1.07
Price-Earnings ratio-1.07
Dividend yield
Dividend yield
Average volume
1.37M
Average volume1.37M
High today
$4.71
High today$4.71
Low today
$4.39
Low today$4.39
Open price
$4.41
Open price$4.41
Volume
1.26M
Volume1.26M
52 Week high
$8.59
52 Week high$8.59
52 Week low
$3.53
52 Week low$3.53

Stock Snapshot

As of today, Myriad Genetics(MYGN) shares are valued at $4.63. The company's market cap stands at 437.3M, with a P/E ratio of -1.07.

On 2026-06-24, Myriad Genetics(MYGN) stock moved within a range of $4.39 to $4.71. With shares now at $4.63, the stock is trading +5.5% above its intraday low and -1.7% below the session's peak.

Trading activity shows a volume of 1.26M, compared to an average daily volume of 1.37M.

Over the past 52 weeks, Myriad Genetics(MYGN) stock has traded between a high of $8.59 and a low of $3.53.

Over the past 52 weeks, Myriad Genetics(MYGN) stock has traded between a high of $8.59 and a low of $3.53.

MYGN News

Investing.com 19h
Myriad Genetics expands cancer detection test availability - Investing.com

...

Myriad Genetics expands cancer detection test availability - Investing.com
TipRanks 20h
Myriad Genetics Announces Resignation of Board Member Skovronsky

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Analyst ratings

56%

of 9 ratings
Buy
22.2%
Hold
55.6%
Sell
22.2%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.